Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Boehringer Ingelheim posts Brightline-2 brigimadlin results; BI 4060107 trial recruitsOct 15Weekly roundup, 5 itemsBoehringer Ingelheimempagliflozin
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
Harrow to acquire global rights to TYRVAYA nasal spray from ViatrisAug 6Regulatory decisioncyclosporine ophthalmic solutionHarrow Inc